US biotech giant Pfizer will ramp up manufacturing of antimicrobials and precision medicines from its Melbourne site to combat the rising threat of superbugs after tipping $150 million into...
The national science agency has partnered with a deep tech incubator to try and build out a local industry for antimicrobial resistance products, warning the pipeline for new “superbug”...